|
US4911920A
(en)
|
1986-07-30 |
1990-03-27 |
Alcon Laboratories, Inc. |
Sustained release, comfort formulation for glaucoma therapy
|
|
FR2588189B1
(fr)
|
1985-10-03 |
1988-12-02 |
Merck Sharp & Dohme |
Composition pharmaceutique de type a transition de phase liquide-gel
|
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
|
US4801575A
(en)
|
1986-07-30 |
1989-01-31 |
The Regents Of The University Of California |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
|
US5624898A
(en)
|
1989-12-05 |
1997-04-29 |
Ramsey Foundation |
Method for administering neurologic agents to the brain
|
|
US6407061B1
(en)
|
1989-12-05 |
2002-06-18 |
Chiron Corporation |
Method for administering insulin-like growth factor to the brain
|
|
DK0495421T3
(da)
|
1991-01-15 |
1996-12-09 |
Alcon Lab Inc |
Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
|
|
US5212162A
(en)
|
1991-03-27 |
1993-05-18 |
Alcon Laboratories, Inc. |
Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
|
|
US6287792B1
(en)
|
1991-06-17 |
2001-09-11 |
The Regents Of The University Of California |
Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology
|
|
TW282460B
(enExample)
|
1993-12-28 |
1996-08-01 |
Yamanouchi Pharma Co Ltd |
|
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
|
US5728718A
(en)
|
1994-12-20 |
1998-03-17 |
The United States Of America As Represented By The Department Of Health And Human Services |
2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
|
|
EP1194449B1
(en)
|
1999-06-28 |
2010-09-22 |
Oklahoma Medical Research Foundation |
Inhibitors of memapsin 2 and use thereof
|
|
EP1237872B1
(en)
|
1999-12-16 |
2008-02-27 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
IL151910A0
(en)
|
2000-04-12 |
2003-04-10 |
Implyx Ltd |
Compositions for drug delivery
|
|
US6372250B1
(en)
|
2000-04-25 |
2002-04-16 |
The Regents Of The University Of California |
Non-invasive gene targeting to the brain
|
|
CA2410680A1
(en)
|
2000-06-30 |
2002-01-10 |
Elan Pharmaceuticals, Inc. |
Compounds to treat alzheimer's disease
|
|
PE20020276A1
(es)
|
2000-06-30 |
2002-04-06 |
Elan Pharm Inc |
COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
|
|
US6846813B2
(en)
|
2000-06-30 |
2005-01-25 |
Pharmacia & Upjohn Company |
Compounds to treat alzheimer's disease
|
|
US20040121947A1
(en)
|
2000-12-28 |
2004-06-24 |
Oklahoma Medical Research Foundation |
Compounds which inhibit beta-secretase activity and methods of use thereof
|
|
EP1404718A2
(en)
|
2000-12-28 |
2004-04-07 |
Oklahoma Medical Research Foundation |
Inhibitors of memapsin 2 and use thereof
|
|
WO2002064558A2
(en)
|
2001-02-14 |
2002-08-22 |
Sankyo Company, Limited |
Oxazole derivatives, their preparation and their use as cytokine inhibitors
|
|
US20060234944A1
(en)
|
2001-10-23 |
2006-10-19 |
Oklahoma Medical Reseach Foundation |
Beta-secretase inhibitors and methods of use
|
|
EP1448218A4
(en)
|
2001-10-23 |
2009-01-14 |
Oklahoma Med Res Found |
BETA SECRETASE INHIBITORS AND METHOD OF USE
|
|
AR039555A1
(es)
|
2001-11-08 |
2005-02-23 |
Upjohn Co |
Derivados n,n'-sustituidos de 1,3-diamino-2-hidroxipropano
|
|
WO2003050073A1
(en)
|
2001-12-06 |
2003-06-19 |
Elan Pharmaceuticals, Inc. |
Substituted hydroxyethylamines
|
|
HRP20040857A2
(en)
|
2002-02-27 |
2005-06-30 |
Pharmacia & Upjohn Company Elan Pharmaceuticals |
Substituted hydroxyethylamines
|
|
AU2003220115A1
(en)
|
2002-05-20 |
2003-12-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone, and other tissues
|
|
RU2357962C2
(ru)
|
2002-09-06 |
2009-06-10 |
Элан Фармасьютикалз, Инк. |
Пролекарственные производные 1,3-диамино-2-гидроксипропана
|
|
DE60329316D1
(de)
|
2002-11-12 |
2009-10-29 |
Merck & Co Inc |
Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
|
|
US20040102369A1
(en)
|
2002-11-27 |
2004-05-27 |
The Regents Of The University Of California |
Transport of basic fibroblast growth factor across the blood brain barrier
|
|
US7388079B2
(en)
|
2002-11-27 |
2008-06-17 |
The Regents Of The University Of California |
Delivery of pharmaceutical agents via the human insulin receptor
|
|
GB0228410D0
(en)
|
2002-12-05 |
2003-01-08 |
Glaxo Group Ltd |
Novel Compounds
|
|
GB0305918D0
(en)
|
2003-03-14 |
2003-04-23 |
Glaxo Group Ltd |
Novel compounds
|
|
CA2534950A1
(en)
|
2003-08-08 |
2005-02-24 |
Schering Corporation |
Cyclic amine bace-1 inhibitors having a benzamide substituent
|
|
KR100793095B1
(ko)
|
2003-10-01 |
2008-01-10 |
주식회사 프로메디텍 |
Ｂａｃｅ 저해효능을 가진 신규한 술폰 아미드 유도체
|
|
JP2007517781A
(ja)
|
2003-12-19 |
2007-07-05 |
メルク エンド カムパニー インコーポレーテッド |
アルツハイマー病治療用のフェニルアミドおよびピリジルアミド系β−セクレターゼ阻害薬
|
|
US7618978B2
(en)
|
2004-04-22 |
2009-11-17 |
Eli Lilly And Company |
Amides as BACE inhibitors
|
|
US7585885B2
(en)
|
2004-04-22 |
2009-09-08 |
Eli Lilly And Company |
Pyrrolidine derivatives useful as BACE inhibitors
|
|
EP1758854B1
(en)
|
2004-06-15 |
2014-07-16 |
Merck Sharp & Dohme Corp. |
Pyrrolidin-3-yl compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
|
|
US8436006B2
(en)
|
2004-08-06 |
2013-05-07 |
Jansssen Pharmaceutica N.V. |
2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
|
|
US7659289B2
(en)
|
2004-09-17 |
2010-02-09 |
Comentis, Inc. |
Hydroxyethylene-based β-secretase inhibitors and use thereof
|
|
JP2008513495A
(ja)
|
2004-09-17 |
2008-05-01 |
コメンティス，インコーポレーテッド |
ベータ−セクレターゼ活性を阻害する二環式化合物およびその使用方法
|
|
CN100475786C
(zh)
*
|
2005-02-18 |
2009-04-08 |
中国科学院上海药物研究所 |
一类4-羟基戊酰胺类化合物及其制备方法和用途
|
|
WO2006099352A1
(en)
|
2005-03-10 |
2006-09-21 |
Bristol-Myers Squibb Company |
Novel isophthalates as beta-secretase inhibitors
|
|
MX2007012341A
(es)
|
2005-04-08 |
2008-02-12 |
Comentis Inc |
Compuestos que inhiben actividad beta-secretasa y metodos de uso de los mismos.
|
|
MY144968A
(en)
|
2005-04-11 |
2011-11-30 |
Xenon Pharmaceuticals Inc |
Spiro-oxindole compounds and their uses as therapeutic agents
|
|
AR054363A1
(es)
|
2005-05-23 |
2007-06-20 |
Astrazeneca Ab |
Compuestos que exhiben actividad moduladora en el receptor 5-hidroxi-triptamina 6
|
|
AR054044A1
(es)
|
2005-05-23 |
2007-05-30 |
Astrazeneca Ab |
Derivados de cromano y tetrahidronaftaleno como moduladores del receptor 5 - ht6; intermediarios en su preparacion; composiciones farmaceuticas que los contienen y su empelo en la fabricacion de medicamentos para el tratamiento de enfermedades del snc y de la obesidad.
|
|
GB0513886D0
(en)
|
2005-07-06 |
2005-08-10 |
Glaxo Group Ltd |
Novel compounds
|
|
US7476764B2
(en)
|
2005-08-04 |
2009-01-13 |
Bristol-Myers Squibb Company |
Phenylcarboxyamides as beta-secretase inhibitors
|
|
US7790745B2
(en)
|
2005-10-21 |
2010-09-07 |
Bristol-Myers Squibb Company |
Tetrahydroisoquinoline LXR Modulators
|
|
TW200804290A
(en)
|
2005-11-15 |
2008-01-16 |
Astrazeneca Ab |
Compounds and uses thereof
|
|
CA2664130A1
(en)
|
2006-09-21 |
2008-03-27 |
Merck & Co., Inc. |
Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
|
|
EP2178837A2
(en)
|
2007-07-26 |
2010-04-28 |
Comentis, Inc. |
Isophthalamide derivatives inhibiting beta-secretase activity
|
|
CN101868457B
(zh)
|
2007-09-24 |
2013-02-13 |
科门蒂斯公司 |
作为β-分泌酶抑制剂用于治疗的(3-羟基-4-氨基-丁-2-基)-3-(2-噻唑-2-基-吡咯烷-1-羰基)苯甲酰胺衍生物和相关化合物
|
|
EP2307345A4
(en)
|
2008-07-01 |
2012-05-02 |
Purdue Research Foundation |
NON-PEPTIDINHIBITORS OF HIV-1 PROTEASE
|
|
US20130102593A1
(en)
|
2008-10-10 |
2013-04-25 |
Geoffrey M. Bilcer |
Pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof
|
|
JP2012505241A
(ja)
|
2008-10-10 |
2012-03-01 |
パーデュー・リサーチ・ファウンデーション |
アルツハイマー病の治療用組成物
|
|
EP2376083A4
(en)
|
2008-11-20 |
2012-06-20 |
Purdue Research Foundation |
QUINAZOLIN-BASED BACE-1 INHIBITORS AND METHODS OF USE
|
|
WO2010065861A2
(en)
|
2008-12-05 |
2010-06-10 |
Purdue Research Foundation |
Inhibitors of bace 1 and methods for treating alzheimer's disease
|
|
EP2411000A4
(en)
|
2009-03-25 |
2012-09-19 |
Comentis Inc |
PYRROLIDIN COMPOUNDS FOR INHIBITING THE BETA-SECRETASE EFFECT AND METHOD FOR THE APPLICATION THEREOF
|
|
JP2013506713A
(ja)
|
2009-10-05 |
2013-02-28 |
コメンティス，インコーポレーテッド |
β−セクレターゼ活性を阻害するスルホンアミドピロリジン化合物及びその使用方法
|